Greater Access to Hepatitis C Treatment Act, 2016 Jones, Sylvia — Bill 5 (41st Parliament, 2nd Session)

Bill 5, 41-2

Ontario — Bills

role="main" class="main-container container js-quickedit-main-content" id="main-content">

Bill 5, Greater Access to Hepatitis C Treatment Act, 2016

Jones, Sylvia

Please select

View bill

Status

Debates

Acts affected

Original

[41] Bill 5 Original (PDF)

Bill 5 2016

Act to amend the Ministry of Health and Long-Term Care Act in respect of

Hepatitis C

Preamble

Approximately

110,000 Ontarians are afflicted with hepatitis C. Nearly half of those

individuals living with hepatitis C are unaware they are infected. Individuals

can live with hepatitis C for many years without realizing the virus is

damaging their liver. If left untreated, hepatitis C can lead to cirrhosis,

liver cancer, the need for a liver transplant or death.

However,

hepatitis C is curable. New treatments have a 95 per cent effectiveness rate in

curing individuals with hepatitis C. However, obtaining access to these new

treatments in Ontario requires an individual to meet restrictive clinical

criteria that demand that an individual's liver be at stage 2 or greater of

fibrosis before the individual is eligible for publicly-funded treatment.

Ontario

can take a leadership role in ending the single most burdensome infectious

disease in Canada by allowing all individuals access to these new highly

effective treatments no matter the stage of the disease.

Therefore,

Her Majesty, by and with the advice and consent of the Legislative Assembly of

the Province of Ontario, enacts as follows:

1. Subsection

6 (1) of the Ministry of Health and Long-Term Care Act

is amended by adding the following paragraph:

12. To

ensure that any treatment recommended by a physician for a patient with

hepatitis C is provided to the patient irrespective of the degree or amount of

liver damage sustained by the patient.

Commencement

2. This

Act comes into force on the day it receives Royal Assent.

Short

title

3. The

short title of this Act is the Greater Access to Hepatitis

C Treatment Act, 2016 .

EXPLANATORY

NOTE

The

Bill amends the Ministry of Health and Long-Term Care Act

to set out an additional duty for the Minister of Health and Long-Term Care

with respect to patients with hepatitis C.

Date Bill stage Activity Committee

September 13, 2016

First Reading

Carried

Debates and Progress

First Reading

September 13, 2016

test

Committee

Second Reading

Committee

Third Reading

Royal Assent

Acts affected - Bill 5

Most Ontario public acts are available electronically; to view copies of the Acts to be amended by this bill visit e-laws

Ministry of Health and Long-Term Care Act

Legislative Assembly of Ontario

Was this page helpful? Yes , I found this page helpful. An optional survey will open in a new tab. No , I didn’t find this page helpful. An optional survey will open in a new tab.

Back to top

Document details

Collection	Ontario — Bills
Citation	Bill 5, 41-2
Type	bill
Volume / chapter	p41 s2 bill 5 html
Language	en
Format	html
Source	PROVINCIAL
Identifier	757ee099ee71c03ea7db5b417f11733b78ead703

Source file is stored in the law ingest library (html).